Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Aug;135(Suppl 5):675-687.
doi: 10.1007/s00508-023-02263-8. Epub 2023 Sep 20.

[Diagnostic and therapy of lupus nephritis - 2023]

[Article in German]
Balazs Odler  1 , Marion J Pollheimer  2 , Andreas Kronbichler  3 , Marcus D Säemann  4   5 , Martin Windpessl  6   7 , Philipp Gauckler  3 , Michael Rudnicki  3 , Emanuel Zitt  8 , Irmgard Neumann  9   10 , Karl Lhotta  8 , Kathrin Eller  11
Affiliations

[Diagnostic and therapy of lupus nephritis - 2023]

[Article in German]
Balazs Odler et al. Wien Klin Wochenschr. 2023 Aug.

Abstract
in English, German

The manuscript summarizes the consensus of the Austrian Society of Nephrology on the diagnosis and therapy of lupusnephritis, which is built on existing studies and literature. We discuss in detail the immunosuppressive treatment in proliferative forms of lupusnephritis (III and IV ± V) and in pure lupusnephritis V with nephrotic-range proteinuria. Furthermore, the supportive medication in lupusnephritis is summarized in the consensus. The figures were designed to provide the reader a guidance through the therapeutical approach in lupusnephritis for the daily practice.

Das vorliegende Manuskript fasst die Empfehlungen der Österreichischen Gesellschaft für Nephrologie zur Diagnose und Therapie der Lupusnephritis zusammen und erläutert die Hintergründe der entsprechenden Empfehlungen anhand der vorhandenen Literatur. Wir besprechen im Detail die immunsuppressive Therapie in proliferativen Stadien der Lupusnephritis (Stadium III und IV mit/ohne Stadium V) und in der Lupusnephritis im reinen Stadium V mit großer Proteinurie. Zudem wird auch die konservative, supportive Therapie der Lupusnephritis detailliert besprochen. In den Abbildungen haben wir versucht, einen Leitfaden für die Praxis zur Therapie der Lupusnephritis zu erstellen.

Keywords: Immunosuppression; Proliferative lupus nephritis; Proteinuria; Supportive therapy.

PubMed Disclaimer

Similar articles

See all similar articles

References

    1. Almaani S, Meara A, Rovin BH. Update on lupus nephritis. Clin J Am Soc Nephrol. 2017;12(5):825–835. doi: 10.2215/CJN.05780616. - DOI - PMC - PubMed
    1. Parikh SV, Almaani S, Brodsky S, Rovin BH. Update on lupus nephritis: core curriculum 2020. Am J Kidney Dis. 2020;76(2):265–281. doi: 10.1053/j.ajkd.2019.10.017. - DOI - PubMed
    1. Aringer M, Costenbader K, Daikh D, Brinks R, Mosca M, Ramsey-Goldman R, et al. 2019 European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Arthritis Rheumatol. 2019;71(9):1400–1412. doi: 10.1002/art.40930. - DOI - PMC - PubMed
    1. Giannico G, Fogo AB. Lupus nephritis: is the kidney biopsy currently necessary in the management of lupus nephritis? Clin J Am Soc Nephrol. 2013;8(1):138–145. doi: 10.2215/CJN.03400412. - DOI - PubMed
    1. Corwin HL, Schwartz MM, Lewis EJ. The importance of sample size in the interpretation of the renal biopsy. Am J Nephrol. 1988;8(2):85–89. doi: 10.1159/000167563. - DOI - PubMed

Publication types

LinkOut - more resources